A critical advance in cancer research is emerging with the use of VHH fragments to re-engage dysfunctional p53. This vital cancer inhibitor protein is frequently disabled in many forms of malignancies, leading https://wavesocialmedia.com/story7691766/nanobodies-restore-p53-the-potential-hope-for-tumor-therapy